1-6 of 6
Mohammed S Alnoamani
Close
Sort by
Journal Articles

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Abdullah M. Alrajhi, Mashael Alrouqi, Jude Howaidi, Mohammmad Alwadi, Hassan Alshehri, Imran K Tailor, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Mohammed A Marei, Muhned Alhumaid
Journal: Blood
Blood (2023) 142 (Supplement 1): 7367.
https://doi.org/10.1182/blood-2023-189082
Published: 2023
Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Manar Aleid, Abdullah Alrajhi, Mohammmad Alwadi, Ali Alsugair, Hassan Alshehri, Imran K Tailor, Amr Hanbali, Feras Abdulaziz Alfraih, Saud Alhayli, Ali Alahmari, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Hazza A Alzahrani, Mohammed A Marei, Ayman Saad, Mahmoud Aljurf, Riad Elfakih, Muhned Alhumaid, Mansour Alfayez
Journal: Blood
Blood (2023) 142 (Supplement 1): 5889.
https://doi.org/10.1182/blood-2023-180221
Published: 2023
Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez
Journal: Blood
Blood (2021) 138 (Supplement 1): 4558.
https://doi.org/10.1182/blood-2021-150242
Published: 2021
Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez
Journal: Blood
Blood (2021) 138 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2021-153335
Published: 2021
Journal Articles

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Maged Al-Ammari, Abdul Ali Peer Zada, Ibraheem H. Motabi, Belal M. Albtoosh, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, Syed Ziauddin A Zaidi, Mansour Alfayez, Nawal F Alshehry, Mohammed A. Marei
Journal: Blood
Blood (2021) 138 (Supplement 1): 4258.
https://doi.org/10.1182/blood-2021-149560
Published: 2021
Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor
Journal: Blood
Blood (2021) 138 (Supplement 1): 4532.
https://doi.org/10.1182/blood-2021-152911
Published: 2021